نبذة مختصرة : Objective: Lymphoproliferative disorders are a group of lesions characterized by abnormal proliferation of lymphocytes. In the orbit, they can occur in the ocular adnexae. These neoplasms have defined clinical and pathologic characteristics and account for more than 20% of all orbital tumors. Several types of lymphoproliferative lesions have been described in the orbit. One example is lymphoid hyperplasia, which commonly involves the lacrimal gland. A benign lesion like lymphoid hyperplasia will show a general normal archetype of the tissues-involved lacrimal gland. We expect a polyclonal group of cells with more or less normal architecture of a follicle. On the other hand, lymphoma will show less organized arrangement of cells, and we expect them to be of monoclonal lineage.Methods: This is a case report of a 55-year-old Filipino female who came in for blurring of vision of both eyes. During her assessment, there was an incidental finding of bilateral upper eyelid swelling, and a 30x15 mm palpable firm mass under the right superior orbital rim and a 30x10 mm mass under the left were noted. The right globe was displaced inferiorly, but no proptosis was seen on exophthalmometry. On plain CT scan, we noted a homogenous mass with molding or contouring around the orbital structures. On coronal view, we noted homogenous masses that mold around the globe and recti, and this also confirmed on axial cuts. A section biopsy was done via anterior orbitotomy.Results: Our patient's histopath had features of both. On scanning magnification, we noted a very cellular round cell tumor. The round cell lesion seemed to be reminiscent of a germinal center of a lymph node. Around it we noticed the glandular structures, which were expected, since this specimen was from the lacrimal gland. A closer view of the lesion on high power showed these lymphocytes within a germinal center. These are large macrophages that actively phagocytose apoptotic lymphoid cells in germinal centers. We expect to see a lot of them in benign hyperplasia, ...
Relation: Honavar SG, Manjandavida FP. Recent Advances in Orbital Tumors - A Review of Publications from 2014-2016. Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):153-8. DOI:10.22608/APO.201736; Hussein MR. Atypical lymphoid proliferations: the pathologist's viewpoint. Expert Rev Hematol. 2013 Apr;6(2):139-53. DOI:10.1586/ehm.13.4; Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990 Sep;21(9):959-73. DOI:10.1016/0046-8177(90)90181-4; Li EY, Yuen HK, Cheuk W. Lymphoproliferative Disease of the Orbit. Asia Pac J Ophthalmol (Phila). 2015 Mar-Apr;4(2):106-11. DOI:10.1097/APO.0000000000000102; Mino T, Mihara K, Yoshida T, Takihara Y, Ichinohe T. Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. Blood Cancer J. 2014 Sep;4:e245. DOI:10.1038/bcj.2014.65; Polito E, Leccisotti A. Prognosis of orbital lymphoid hyperplasia. Graefes Arch Clin Exp Ophthalmol. 1996 Mar;234(3):150-4. DOI:10.1007/BF00462026; Sriram PR. A Rare Case of Aggressive, Huge Primary Orbital Lymphoma with Intracranial Extension and Bone Invasion. Asian J Neurosurg. 2017 Oct-Dec;12(4):766-8. DOI:10.4103/1793-5482.185055; Sullivan TJ, Whitehead K, Williamson R, Grimes D, Schlect D, Brown I, Dickie G. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients. Ophthalmic Plast Reconstr Surg. 2005 May;21(3):177-88. DOI:10.1097/01.iop.0000159173.42243.ad; Talaulikar D, Tridgell D, Leong D, Dahlstrom JE, Cherian M, Prosser I, Sunderland K. Novel therapeutic option for orbital atypical lymphoid hyperplasia. Clin Exp Ophthalmol. 2010 Dec;38(9):892-4. DOI:10.1111/j.1442-9071.2010.02378.x; http://dx.doi.org/10.3205/oc000193; http://nbn-resolving.de/urn:nbn:de:0183-oc0001936; http://www.egms.de/en/journals/oc/2022-12/oc000193.shtml
No Comments.